Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Poolbeg Pharma Ltd. ( (GB:POLB) ) has issued an announcement.
Poolbeg Pharma Ltd. and HOOKIPA Pharma Inc. announced a potential merger, but all discussions remain non-binding and non-exclusive, with no certainty that a formal offer will be made. Gilead Sciences Inc. has expressed its intention to participate in the proposed concurrent fundraise with an investment of up to $8.7495 million, aligning with its existing contractual obligations, indicating potential interest and support from a major industry player.
More about Poolbeg Pharma Ltd.
Poolbeg Pharma Ltd. is a pharmaceutical company operating in the healthcare industry, focusing on the development of infectious disease treatments. The company is involved in researching and developing innovative medical solutions to address unmet clinical needs.
YTD Price Performance: -32.96%
Average Trading Volume: 2,058,167
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of POLB stock, go to TipRanks’ Stock Analysis page.
